Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.

Alexis A, McMichael A, Soung J, Choi O, Alkousakis T, Alonso-Llamazares J, Shahriari M, Rodriguez AO, Bhutani T, Chan D, Rowland K, Sauder M, Hong HC, Yadav G, Yeung J, Jeyarajah J, Ma T, Gao LL, Park-Wyllie L, Green L, Lee M, Vashi N, Kindred C, Grimes P, Taylor SC, Desai SR, VISIBLE Trial Investigators

Open source

DOI: 10.1001/jamadermatol.2025.1836
Published: 2025 Sep 1
Container: JAMA dermatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2025.1836,
  title = {Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.},
  author = {Alexis A and McMichael A and Soung J and Choi O and Alkousakis T and Alonso-Llamazares J and Shahriari M and Rodriguez AO and Bhutani T and Chan D and Rowland K and Sauder M and Hong HC and Yadav G and Yeung J and Jeyarajah J and Ma T and Gao LL and Park-Wyllie L and Green L and Lee M and Vashi N and Kindred C and Grimes P and Taylor SC and Desai SR and VISIBLE Trial Investigators},
  year = {2025},
  journal = {JAMA dermatology},
  doi = {10.1001/jamadermatol.2025.1836},
  url = {https://doi.org/10.1001/jamadermatol.2025.1836}
}

RIS

TY  - JOUR
TI  - Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.
AU  - Alexis A
AU  - McMichael A
AU  - Soung J
AU  - Choi O
AU  - Alkousakis T
AU  - Alonso-Llamazares J
AU  - Shahriari M
AU  - Rodriguez AO
AU  - Bhutani T
AU  - Chan D
AU  - Rowland K
AU  - Sauder M
AU  - Hong HC
AU  - Yadav G
AU  - Yeung J
AU  - Jeyarajah J
AU  - Ma T
AU  - Gao LL
AU  - Park-Wyllie L
AU  - Green L
AU  - Lee M
AU  - Vashi N
AU  - Kindred C
AU  - Grimes P
AU  - Taylor SC
AU  - Desai SR
AU  - VISIBLE Trial Investigators
PY  - 2025
JO  - JAMA dermatology
DO  - 10.1001/jamadermatol.2025.1836
UR  - https://doi.org/10.1001/jamadermatol.2025.1836
ER  -

APA

A, A., A, M., J, S., O, C., T, A., J, A., M, S., AO, R., T, B., D, C., K, R., M, S., HC, H., G, Y., J, Y., J, J., T, M., LL, G., L, P., L, G., M, L., N, V., C, K., P, G., SC, T., SR, D., & Investigators, V. T. (2025). Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.. JAMA dermatology. https://doi.org/10.1001/jamadermatol.2025.1836

Source records

pubmed · retrieved 2026-09-26T08:33:44.776Z
europe-pmc · retrieved 2026-09-26T08:33:44.786Z